BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: Etiology, clinical outcomes. World J Gastroenterol 2007; 13(18): 2535-2540 [PMID: 17552000 DOI: 10.3748/wjg.v13.i18.2535] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Olveda DU, Olveda RM, Montes CJ, Chy D, Abellera JM 3rd, Cuajunco D, Lam AK, McManus DP, Li Y, Ross AG. Clinical management of advanced schistosomiasis: a case of portal vein thrombosis-induced splenomegaly requiring surgery. BMJ Case Rep 2014;2014:bcr2014203897. [PMID: 24939453 DOI: 10.1136/bcr-2014-203897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:215-23. [PMID: 32185400 DOI: 10.1093/ibd/izaa053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Dig Liver Dis. 2018;50:839-844. [PMID: 29429910 DOI: 10.1016/j.dld.2018.01.132] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
4 Farmer AD, Saadeddin A, Bruckner Holt CE, Bateman JM, Ahmed M, Syn WK. Portal vein thrombosis in the district general hospital: management and clinical outcomes: . European Journal of Gastroenterology & Hepatology 2009;21:517-21. [DOI: 10.1097/meg.0b013e328318ed6b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Maurizio LD, Bombardieri G, Cristofaro RD, Gaetano AMD, Landolfi R, Gasbarrini A. Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16(2): 143-155 [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 148] [Cited by in F6Publishing: 112] [Article Influence: 13.5] [Reference Citation Analysis]
6 Hernández-Conde M, Llop E, Fernández-Carrillo C, Perelló C, López-Gómez M, Abad J, Martínez-Porras JL, Fernández-Puga N, Calleja JL. Visceral fat is associated with cirrhotic portal vein thrombosis. Expert Rev Gastroenterol Hepatol 2019;13:1017-22. [PMID: 31393183 DOI: 10.1080/17474124.2019.1651644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Moerkercke WV, Pauwelyn K, Brugman E, Verhamme M. Cytomegalovirus-associated superior mesenteric vein thrombosis treated with systemic and in-situ thrombolysis: . European Journal of Gastroenterology & Hepatology 2009;21:587-92. [DOI: 10.1097/meg.0b013e3283196b15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Huang YJ, Hsu HC, Wang CY, Wang CJ, Chen HC, Huang EY, Fang FM, Lu SN. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;73:1155-1163. [PMID: 18760547 DOI: 10.1016/j.ijrobp.2008.06.1486] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
9 Wang RY, Wang JF, Liu Q, Ma N, Chen WX, Li JL. Combined Rex-bypass shunt with pericardial devascularization alleviated prehepatic portal hypertension caused by cavernomatous transformation of portal vein. Postgrad Med. 2017;129:768-776. [PMID: 28643575 DOI: 10.1080/00325481.2017.1343646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
11 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 56] [Article Influence: 13.7] [Reference Citation Analysis]
12 Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-894. [PMID: 19678814 DOI: 10.1111/j.1365-2036.2009.04116.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
13 Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a clinician-oriented and practical review. Clin Appl Thromb Hemost. 2014;20:498-506. [PMID: 23364162 DOI: 10.1177/1076029612473515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ayala R, Grande S, Bustelos R, Ribera C, García-Sesma A, Jimenez C, Moreno E, Martínez-López J. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 2012;12:114. [PMID: 22909075 DOI: 10.1186/1471-230X-12-114] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
16 Seijo-ríos S, García-pagán JC. Trombosis portal. Gastroenterología y Hepatología 2010;33:179-90. [DOI: 10.1016/j.gastrohep.2009.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
17 Woodrum DA, Bjarnason H, Andrews JC. Portal vein venoplasty and stent placement in the nontransplant population. J Vasc Interv Radiol. 2009;20:593-599. [PMID: 19339200 DOI: 10.1016/j.jvir.2009.02.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
18 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chatelin S, Pop R, Giraudeau C, Ambarki K, Jin N, Séverac F, Breton E, Vappou J. Influence of portal vein occlusion on portal flow and liver elasticity in an animal model. NMR Biomed 2021;34:e4498. [PMID: 33634498 DOI: 10.1002/nbm.4498] [Reference Citation Analysis]
20 Jain P, Nijhawan S. Portal vein thrombosis: Etiology and clinical outcome of cirrhosis and malignancy-related non-cirrhotic, non-tumoral extrahepatic portal venous obstruction. World J Gastroenterol 2007; 13(39): 5288-5289 [PMID: 17876904 DOI: 10.3748/wjg.v13.i39.5288] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
21 Nasim M, Majid B, Tahir F, Majid Z, Irfan I. Cavernous Transformation of Portal Vein in the Setting of Protein C and Anti-thrombin III Deficiency. Cureus. 2019;11:e5779. [PMID: 31723538 DOI: 10.7759/cureus.5779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Poordad FF, Sigal SH, Brown RS. Pathophysiologic basis for the medical management of portal hypertension. Expert Opin Pharmacother. 2009;10:453-467. [PMID: 19191681 DOI: 10.1517/14656560802707853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Attali J, Heurgue A, Loock M, Thiefin G, Marcus C, Long A. Computed tomography follow-up of acute portal vein thrombosis. Diagnostic and Interventional Imaging 2014;95:579-85. [DOI: 10.1016/j.diii.2014.02.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Kanellopoulou T, Alexopoulou A, Theodossiades G, Koskinas J, Archimandritis AJ. Pylephlebitis: an overview of non-cirrhotic cases and factors related to outcome. Scand J Infect Dis. 2010;42:804-811. [PMID: 20735334 DOI: 10.3109/00365548.2010.508464] [Cited by in Crossref: 83] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
25 Khan J, Pikkarainen P, Karvonen AL, Mäkelä T, Peräaho M, Pehkonen E, Collin P. Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:970-974. [PMID: 19440927 DOI: 10.1080/00365520902964739] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
26 Cai XY, Zhou W, Hong DF, Cai XJ. A latent form of essential thrombocythemia presenting as portal cavernoma. World J Gastroenterol 2009; 15(42): 5368-5370 [PMID: 19908349 DOI: 10.3748/wjg.15.5368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
27 Ramos R, Park Y, Shazad G, A Garcia C, Cohen R. Cavernous transformation of portal vein secondary to portal vein thrombosis: a case report. J Clin Med Res 2012;4:81-4. [PMID: 22383935 DOI: 10.4021/jocmr775w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol 2018;31:315-29. [PMID: 29720857 DOI: 10.20524/aog.2018.0245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Rush N, Sun H, Nakanishi Y, Mneimneh W, Kwo PY, Saxena R. Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis. Mod Pathol 2016;29:489-99. [DOI: 10.1038/modpathol.2016.43] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
30 Ponziani FR, Zocco MA, Tortora A, Gasbarrini A. Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? Expert Opin Pharmacother. 2010;11:1479-1487. [PMID: 20446862 DOI: 10.1517/14656561003749264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
31 You H, Zhao J, Huang C, Tian X, Li M, Zeng X. Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis. Front Med (Lausanne) 2021;8:630660. [PMID: 33614687 DOI: 10.3389/fmed.2021.630660] [Reference Citation Analysis]
32 Dal Zotto C, Wieczorek M, Mariottini G, Malagò R, Olivieri O, De Franceschi L. Persistent abdominal pain related to portal vein thrombosis in young adult with sickle cell disease. Am J Hematol 2018;93:1562-5. [PMID: 30230563 DOI: 10.1002/ajh.25291] [Reference Citation Analysis]